Carbaglu
-
- Application
- Inhibition Assay (InhA), Functional Studies (Func)
- Purpose
- Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death. Carglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.
- Characteristics
-
Tradename: Zemuron
Source of Compound: synthetic
Target: Amino Acids and Derivatives
Receptor: Carbamoyl-phosphate synthase
- Purification
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Purity
- 98 %
- Formula
- C6H10N2O5
- Solubility
- 10 mM in H2O
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Solid
- Storage
- -20 °C
- Storage Comment
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Expiry Date
- 24 months
-
- Background
- Amino Acids & Building Blocks
- Molecular Weight
- 190.15 g/mol
- CAS-No
- 1188-38-1
-